A Study of BMS-562086 in Patients With Irritable Bowel Syndrome

NCT00399438 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Placebo
DRUG: BMS-562086

Sponsor

Bristol-Myers Squibb